Cours Freeline Therapeutics Holdings plc
Actions
FRLN
US35655L2060
Recherche biotechnologique et médicale
Dernier transcript sur Freeline Therapeutics Holdings plc
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Markus Hörer
FOU | Founder | - | 01/01/15 |
Michael Parini
CEO | Chief Executive Officer | 49 | 15/03/21 |
Paul Schneider
DFI | Director of Finance/CFO | 54 | 16/05/22 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Chris Hollowood
CHM | Chairman | 50 | 01/12/15 |
Michael Parini
CEO | Chief Executive Officer | 49 | 15/03/21 |
Paul Schneider
DFI | Director of Finance/CFO | 54 | 16/05/22 |
Varia. 1 janv. | Capi. | |
---|---|---|
-2,31% | 103 Md | |
+0,56% | 95,28 Md | |
+1,69% | 22,15 Md | |
-17,37% | 21,02 Md | |
-9,30% | 18,15 Md | |
-41,01% | 16,74 Md | |
-14,85% | 16,05 Md | |
+3,21% | 13,68 Md | |
+33,54% | 12,17 Md |